Clinical Trials at BAMF Health
Why BAMF Health?
When your patients are facing a devastating disease, every option matters. Radiopharmaceuticals are revolutionizing the discovery and treatment of dozens of conditions, and BAMF Health is at the forefront. Our strong relationships with clinical trial sponsors ensure we get access to cutting-edge studies and novel agents.
When you refer a patient to BAMF for a clinical trial, it’s a partnership. We keep you informed, help coordinate patient follow-ups with your team, and provide a safe and exceptional experience.
- Rapid eligibility reviews
- Streamlined enrollment
- Consults within 5 days*
- Seamless communication
- The most advanced imaging technology
- World-leading experts
*Within 5 days of referral and acquisition of medical records
We are currently enrolling patients for the following trials
BAMF Health is working every day to conduct additional clinical trials to improve disease management using molecular imaging and molecularly targeted radiation therapy.
Clinical Trial General Interest Copy link
If you are interested in learning more about participating in a clinical trial, please fill out this form.
Our latest clinical trial updates
BAMF Health Doses First Patient in Lantheus SPARROW Phase 2/3 Registrational Trial in Prostate Cancer
Study advances development of Lantheus’ investigational GRPR-targeted PET imaging program for prostate cancer.
September 28, 2026
Lung Cancer Patient is First in the World to Participate in New Therapy Trial
Angela is the first person in the world to participate in a new clinical trial exploring an investigational radiopharmaceutical therapy.
May 20, 2026
Henry Ford Health and BAMF Health Break Ground on Comprehensive Theranostics Center in Downtown Detroit
BAMF Health and Henry Ford Health officially broke ground on a 45,000-square-foot facility.
April 14, 2026